8gy5
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 8gy5 is ON HOLD Authors: Heo, Y.-S., Jeong, T.J. Description: High-resolution structure of the cemiplimab Fab in complex with PD-1 [[Category: Unre...) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==High-resolution structure of the cemiplimab Fab in complex with PD-1== | |
| - | + | <StructureSection load='8gy5' size='340' side='right'caption='[[8gy5]], [[Resolution|resolution]] 1.98Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[8gy5]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8GY5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8GY5 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.98Å</td></tr> | |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8gy5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8gy5 OCA], [https://pdbe.org/8gy5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8gy5 RCSB], [https://www.ebi.ac.uk/pdbsum/8gy5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8gy5 ProSAT]</span></td></tr> |
| - | [[Category: Heo | + | </table> |
| - | [[Category: Jeong | + | == Disease == |
| + | [https://www.uniprot.org/uniprot/PDCD1_HUMAN PDCD1_HUMAN] Systemic lupus erythematosus;Multiple sclerosis. Systemic lupus erythematosus 2 (SLEB2) [MIM:[https://omim.org/entry/605218 605218]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.<ref>PMID:12402038</ref> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/PDCD1_HUMAN PDCD1_HUMAN] Inhibitory cell surface receptor involved in the regulation of T-cell function during immunity and tolerance. Upon ligand binding, inhibits T-cell effector functions in an antigen-specific manner. Possible cell death inducer, in association with other factors.<ref>PMID:21276005</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Heo Y-S]] | ||
| + | [[Category: Jeong TJ]] | ||
Current revision
High-resolution structure of the cemiplimab Fab in complex with PD-1
| |||||||||||
